9 completed. 9 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Phase 2 | 3 | Completed 3 |
Follow Encephalomyelitis: new trials by email Literature Review of Encephalomyelitis trials Research Report on Encephalomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Stellate Ganglion Block on ME/CFS Bupivacaine Injection - Encephalomyelitis, Myalgic, Chronic Fatigue Syndrome | Phase 1 | Completed | Neuroversion, Inc. | 10 | 2023-03-15 | 2024-12-06 |
| Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects MVA-BN-WEV Dose 1, MVA-BN-WEV Dose 2, MVA-BN-WEV Dose 3 - Equine Encephalitis | Phase 1 | Completed | Bavarian Nordic | 45 | 2019-10-07 | 2020-08-20 |
| VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults VRC-WEVVLP073-00-VP, VRC-GENMIX083-AL-VP - Venezuelan Equine Encephalitis, Western Equine Encephalitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2019-04-02 | 2021-03-24 |
| Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome CT38 - Myalgic Encephalomyelitis, Chronic Fatigue Syndrome | Phase 1 / Phase 2 | Completed | LUCINDA BATEMAN, MD | 17 | 2018-07-23 | 2020-05-12 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects BC 007, NaCl 0.9 % - Healthy Volunteers | Phase 1 | Completed | Berlin Cures GmbH | 74 | 2016-08-01 | 2018-07-18 |
| Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Completed | Ichor Medical Systems Incorporated | 42 | 2013-12-01 | 2015-08-26 |
| Behavioral Insomnia Therapy With Chronic Fatigue Syndrome Cognitive Behavioral Therapy, Usual Care for Chronic Fatigue Syndrome (Active Control Group) - Chronic Fatigue Syndrome, Behavioral Therapy Targeted to Sleep Problems | Phase 1 / Phase 2 | Completed | Duke University | 24 | 2007-09-01 | 2013-03-01 |
| Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) valganciclovir - Chronic Fatigue Syndrome | Phase 1 / Phase 2 | Completed | Stanford University | 30 | 2007-05-01 | 2022-05-27 |
| Autonomic Nervous System and Chronic Fatigue Syndrome Autonomic Function Testing, Saline infusions, L-NMMA trimethaphan - Chronic Fatigue Syndrome, Orthostatic Intolerance | Phase 1 | Completed | Vanderbilt University | 170 | 2007-04-01 | 2017-01-18 |
Fatigue Syndrome, Chronic (6) · Encephalomyelitis, Venezuelan Equine (2) · Orthostatic Intolerance (2) · Alphavirus Infections (1) · Cardiomyopathies (1) · Encephalomyelitis, Eastern Equine (1) · Encephalomyelitis, Equine (1) · Encephalomyelitis, Western Equine (1) · Epstein-Barr Virus Infections (1) · Familial Primary Pulmonary Hypertension (1) · Fatigue (1) · Heart Failure (1) · Herpes Simplex (1) · Mental Fatigue (1) · Postural Orthostatic Tachycardia Syndrome (1)
Nervous System Diseases (9) · Neuroinflammatory Diseases (9) · Chronic Disease (6) · Disease Attributes (6) · Muscular Diseases (6) · Musculoskeletal Diseases (6) · Neuromuscular Diseases (6) · Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Infections (4) · Virus Diseases (4) · Arbovirus Infections (3) · Brain Diseases (3) · Central Nervous System Diseases (3)
Bupivacaine (1) · Cognitive Behavioral Therapy (1) · Methyldopa (1) · Sodium Chloride (1) · Valganciclovir (1) · aluminum sulfate (1)
Bavarian Nordic (1) · Berlin Cures GmbH (1) · Duke University (1) · Ichor Medical Systems Incorporated (1) · LUCINDA BATEMAN, MD (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Neuroversion, Inc. (1) · Stanford University (1) · Vanderbilt University (1)
United States (8) · Germany (1)
Andrew Krystal, M.D. (1) · Angela Sinn, Dr. (1) · Carlos Fierro, MD (1) · Deborah L Duricka, PhD (1) · Grace Chen, MD (1) · Italo Biaggioni, MD (1) · Jose G Montoya, MD (1) · Julie E Ledgerwood, DO (1) · Lucinda Bateman, MD (1) · Mark Mayo (1) · Pam Smith (1) · Suzanne D Vernon, PhD (1)
PMID 21906029, PMID 23959519, PMID 27206386, PMID 32222912, PMID 34539356, PMID 35568049, PMID 38494412
2015 (1), R21NR010539 (1)